218 related articles for article (PubMed ID: 31271052)
1. Collagen VII Expression Is Required in Both Keratinocytes and Fibroblasts for Anchoring Fibril Formation in Bilayer Engineered Skin Substitutes.
Supp DM; Hahn JM; Combs KA; McFarland KL; Schwentker A; Boissy RE; Boyce ST; Powell HM; Lucky AW
Cell Transplant; 2019; 28(9-10):1242-1256. PubMed ID: 31271052
[TBL] [Abstract][Full Text] [Related]
2. Restoration of type VII collagen expression and function in dystrophic epidermolysis bullosa.
Chen M; Kasahara N; Keene DR; Chan L; Hoeffler WK; Finlay D; Barcova M; Cannon PM; Mazurek C; Woodley DT
Nat Genet; 2002 Dec; 32(4):670-5. PubMed ID: 12426566
[TBL] [Abstract][Full Text] [Related]
3. Lentiviral Engineered Fibroblasts Expressing Codon-Optimized COL7A1 Restore Anchoring Fibrils in RDEB.
Georgiadis C; Syed F; Petrova A; Abdul-Wahab A; Lwin SM; Farzaneh F; Chan L; Ghani S; Fleck RA; Glover L; McMillan JR; Chen M; Thrasher AJ; McGrath JA; Di WL; Qasim W
J Invest Dermatol; 2016 Jan; 136(1):284-92. PubMed ID: 26763448
[TBL] [Abstract][Full Text] [Related]
4. Keratinocyte-/fibroblast-targeted rescue of Col7a1-disrupted mice and generation of an exact dystrophic epidermolysis bullosa model using a human COL7A1 mutation.
Ito K; Sawamura D; Goto M; Nakamura H; Nishie W; Sakai K; Natsuga K; Shinkuma S; Shibaki A; Uitto J; Denton CP; Nakajima O; Akiyama M; Shimizu H
Am J Pathol; 2009 Dec; 175(6):2508-17. PubMed ID: 19893033
[TBL] [Abstract][Full Text] [Related]
5. Safety and Wound Outcomes Following Genetically Corrected Autologous Epidermal Grafts in Patients With Recessive Dystrophic Epidermolysis Bullosa.
Siprashvili Z; Nguyen NT; Gorell ES; Loutit K; Khuu P; Furukawa LK; Lorenz HP; Leung TH; Keene DR; Rieger KE; Khavari P; Lane AT; Tang JY; Marinkovich MP
JAMA; 2016 Nov; 316(17):1808-1817. PubMed ID: 27802546
[TBL] [Abstract][Full Text] [Related]
6. Highly Efficient Ex Vivo Correction of COL7A1 through Ribonucleoprotein-Based CRISPR/Cas9 and Homology-Directed Repair to Treat Recessive Dystrophic Epidermolysis Bullosa.
Berthault C; Gaucher S; Gouin O; Schmitt A; Chen M; Woodley D; Titeux M; Hovnanian A; Izmiryan A
J Invest Dermatol; 2024 Jun; 144(6):1322-1333.e13. PubMed ID: 38043638
[TBL] [Abstract][Full Text] [Related]
7. Murine type VII collagen distorts outcome in human skin graft mouse model for dystrophic epidermolysis bullosa.
Bremer J; Kramer D; Eichhorn DS; Gostyński A; Diercks GFH; Jonkman MF; van den Akker PC; Pasmooij AMG
Exp Dermatol; 2019 Oct; 28(10):1153-1155. PubMed ID: 30019435
[TBL] [Abstract][Full Text] [Related]
8. Human Mesenchymal Stromal Cells Engineered to Express Collagen VII Can Restore Anchoring Fibrils in Recessive Dystrophic Epidermolysis Bullosa Skin Graft Chimeras.
Petrova A; Georgiadis C; Fleck RA; Allison L; McGrath JA; Dazzi F; Di WL; Qasim W
J Invest Dermatol; 2020 Jan; 140(1):121-131.e6. PubMed ID: 31326396
[TBL] [Abstract][Full Text] [Related]
9. Normal and gene-corrected dystrophic epidermolysis bullosa fibroblasts alone can produce type VII collagen at the basement membrane zone.
Woodley DT; Krueger GG; Jorgensen CM; Fairley JA; Atha T; Huang Y; Chan L; Keene DR; Chen M
J Invest Dermatol; 2003 Nov; 121(5):1021-8. PubMed ID: 14708601
[TBL] [Abstract][Full Text] [Related]
10. Construction of skin equivalents for gene therapy of recessive dystrophic epidermolysis bullosa.
Gache Y; Baldeschi C; Del Rio M; Gagnoux-Palacios L; Larcher F; Lacour JP; Meneguzzi G
Hum Gene Ther; 2004 Oct; 15(10):921-33. PubMed ID: 15585108
[TBL] [Abstract][Full Text] [Related]
11. Response of intractable skin ulcers in recessive dystrophic epidermolysis bullosa patients to an allogeneic cultured dermal substitute.
Natsuga K; Sawamura D; Goto M; Homma E; Goto-Ohguchi Y; Aoyagi S; Akiyama M; Kuroyanagi Y; Shimizu H
Acta Derm Venereol; 2010 Mar; 90(2):165-9. PubMed ID: 20169300
[TBL] [Abstract][Full Text] [Related]
12. Epidermal aspects of type VII collagen: Implications for dystrophic epidermolysis bullosa and epidermolysis bullosa acquisita.
Watanabe M; Natsuga K; Shinkuma S; Shimizu H
J Dermatol; 2018 May; 45(5):515-521. PubMed ID: 29352483
[TBL] [Abstract][Full Text] [Related]
13. Revertant mosaic fibroblasts in recessive dystrophic epidermolysis bullosa.
Twaroski K; Eide C; Riddle MJ; Xia L; Lees CJ; Chen W; Mathews W; Keene DR; McGrath JA; Tolar J
Br J Dermatol; 2019 Dec; 181(6):1247-1253. PubMed ID: 30924923
[TBL] [Abstract][Full Text] [Related]
14. Gene-Corrected Fibroblast Therapy for Recessive Dystrophic Epidermolysis Bullosa using a Self-Inactivating COL7A1 Retroviral Vector.
Jacków J; Titeux M; Portier S; Charbonnier S; Ganier C; Gaucher S; Hovnanian A
J Invest Dermatol; 2016 Jul; 136(7):1346-1354. PubMed ID: 26994967
[TBL] [Abstract][Full Text] [Related]
15. Transplanted bone marrow-derived circulating PDGFRα+ cells restore type VII collagen in recessive dystrophic epidermolysis bullosa mouse skin graft.
Iinuma S; Aikawa E; Tamai K; Fujita R; Kikuchi Y; Chino T; Kikuta J; McGrath JA; Uitto J; Ishii M; Iizuka H; Kaneda Y
J Immunol; 2015 Feb; 194(4):1996-2003. PubMed ID: 25601922
[TBL] [Abstract][Full Text] [Related]
16. Induced pluripotent stem cells from individuals with recessive dystrophic epidermolysis bullosa.
Tolar J; Xia L; Riddle MJ; Lees CJ; Eide CR; McElmurry RT; Titeux M; Osborn MJ; Lund TC; Hovnanian A; Wagner JE; Blazar BR
J Invest Dermatol; 2011 Apr; 131(4):848-56. PubMed ID: 21124339
[TBL] [Abstract][Full Text] [Related]
17. Potential of fibroblast cell therapy for recessive dystrophic epidermolysis bullosa.
Wong T; Gammon L; Liu L; Mellerio JE; Dopping-Hepenstal PJ; Pacy J; Elia G; Jeffery R; Leigh IM; Navsaria H; McGrath JA
J Invest Dermatol; 2008 Sep; 128(9):2179-89. PubMed ID: 18385758
[TBL] [Abstract][Full Text] [Related]
18. Epidermal or Dermal Collagen VII Is Sufficient for Skin Integrity: Insights to Anchoring Fibril Homeostasis.
Conradt G; Hausser I; Nyström A
J Invest Dermatol; 2024 Jun; 144(6):1301-1310.e7. PubMed ID: 38007090
[TBL] [Abstract][Full Text] [Related]
19. Gentamicin induces functional type VII collagen in recessive dystrophic epidermolysis bullosa patients.
Woodley DT; Cogan J; Hou Y; Lyu C; Marinkovich MP; Keene D; Chen M
J Clin Invest; 2017 Aug; 127(8):3028-3038. PubMed ID: 28691931
[TBL] [Abstract][Full Text] [Related]
20. Targeted Exon Skipping Restores Type VII Collagen Expression and Anchoring Fibril Formation in an In Vivo RDEB Model.
Turczynski S; Titeux M; Tonasso L; Décha A; Ishida-Yamamoto A; Hovnanian A
J Invest Dermatol; 2016 Dec; 136(12):2387-2395. PubMed ID: 27498345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]